1. Home
  2. CACI vs CORT Comparison

CACI vs CORT Comparison

Compare CACI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • CORT
  • Stock Information
  • Founded
  • CACI 1962
  • CORT 1998
  • Country
  • CACI United States
  • CORT United States
  • Employees
  • CACI N/A
  • CORT N/A
  • Industry
  • CACI EDP Services
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CACI Technology
  • CORT Health Care
  • Exchange
  • CACI Nasdaq
  • CORT Nasdaq
  • Market Cap
  • CACI 10.9B
  • CORT 7.6B
  • IPO Year
  • CACI 1979
  • CORT N/A
  • Fundamental
  • Price
  • CACI $495.79
  • CORT $75.18
  • Analyst Decision
  • CACI Strong Buy
  • CORT Strong Buy
  • Analyst Count
  • CACI 14
  • CORT 4
  • Target Price
  • CACI $544.50
  • CORT $139.00
  • AVG Volume (30 Days)
  • CACI 189.6K
  • CORT 675.5K
  • Earning Date
  • CACI 10-22-2025
  • CORT 10-29-2025
  • Dividend Yield
  • CACI N/A
  • CORT N/A
  • EPS Growth
  • CACI 20.00
  • CORT N/A
  • EPS
  • CACI 22.32
  • CORT 1.11
  • Revenue
  • CACI $8,627,824,000.00
  • CORT $716,080,000.00
  • Revenue This Year
  • CACI $9.97
  • CORT $30.62
  • Revenue Next Year
  • CACI $5.29
  • CORT $37.68
  • P/E Ratio
  • CACI $22.25
  • CORT $67.23
  • Revenue Growth
  • CACI 12.64
  • CORT 25.71
  • 52 Week Low
  • CACI $318.60
  • CORT $38.68
  • 52 Week High
  • CACI $588.26
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • CACI 58.58
  • CORT 60.68
  • Support Level
  • CACI $485.27
  • CORT $69.03
  • Resistance Level
  • CACI $498.89
  • CORT $74.79
  • Average True Range (ATR)
  • CACI 11.04
  • CORT 2.69
  • MACD
  • CACI 1.77
  • CORT 0.32
  • Stochastic Oscillator
  • CACI 91.44
  • CORT 95.68

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: